Innovative singum modeling approach for hybrid lattice materials enhances the design and mechanical performance of absorbent products like diapers and menstrual pads by simulating SAP particle interaction and mechanical properties under various conditions.
This solution presents an advanced singum modeling approach designed to optimize the mechanical performance and design of hybrid lattice materials used in absorbent products such as diapers and menstrual pads. The core innovation is the integration of superabsorbent polymer (SAP) particles within a 3D textile lattice, enhancing absorbency and structural integrity. By examining the interaction of SAP with the lattice, this model predicts the prestress and mechanical behavior of the material, offering a new paradigm for product design.
Currently at TRL 3, this technology has been validated through significant academic research and publications. Ongoing efforts focus on further exploring cellular lattice behaviors, SAP interactions, and the effects of environmental factors such as heat and moisture. Future development includes the application of this model in the design and manufacture of absorbent products via 3D textile technologies.
Columbia University is a comprehensive private research university in New York City, combining an Ivy League academic profile with globally engaged scholarship and professional education. Its integration with a major hospital system through Columbia University Irving Medical Center and NewYork-Presbyterian enables clinical collaboration, access to diverse patient populations, and regulated studies at scale. State-of-the-art laboratories and shared core facilities across the Morningside and Manhattanville campuses support co-located industry projects, while proximity to New York’s finance, media, and healthcare ecosystems streamlines talent pipelines and pilot deployments. Industry engages via sponsored research, affiliate programs, executive education, and convenings that connect faculty expertise with corporate R&D priorities. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD, alongside New York State and philanthropic sources. Columbia Technology Ventures provides IP management, licensing, startup support, and translational funding mechanisms that lower barriers to commercialization.